Clinical Trial

Combining Ketamine with Exposure Therapy for PTSD

Study Description

Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy

The purpose of this study is to combine a single infusion of Ketamine with 7-days of trauma focus psychotherapy to relieve post traumatic stress disorder (PTSD) symptoms more effectively. This treatment has the potential to produce a significant therapeutic effect that otherwise would take months to occur.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Ketamine

Prolonged exposure therapy combined with a single infusion of 0.50 mg/kg/hour for 40 min on day 2.

Drug - Midazolam

Prolonged exposure therapy combined with a single infusion of 0.045 mg/kg/hour for 40 min on day 2.

Additional Information

Official Study Title

Combining Neurobiology and New Learning: Ketamine and Prolonged Exposure: A Potential Rapid Treatment for Post Traumatic Stress Disorder (PTSD)

Clinical Trial ID

NCT02727998

ParticipAid ID

Pe9Xzd